Register today to recieve a live product demonstration at booth 503 or for the industry workshop Cosmic blood flow: Transfusion challenges beyond Earth.
Vitros® syphilis assay is now available on the Vitros 3600 Immunodiagnostic System and Vitros 5600 and Vitros XT 7600 Integrated Systems in the U.S.
This MicroTip® Partnership Assay will help hospitals and emergency rooms respond to the critical demand for enhanced opioid testing
From home to hospital, lab to clinic, we deliver real-time, actionable intelligence powered by industry-leading expertise.
- Join QuidelOrtho at the AABB 2024 Annual Meeting
- QuidelOrtho launches Vitros® Syphilis Assay
- QuidelOrtho adds Fentantyl test to Vitros®
- Changing lives, one test at a time
Committed to people, planet and products
Learn moreInspiring and leading QuidelOrtho
Learn moreFeatured products
Solana® Molecular Testing Platform
Learn moreSofia® Platform
Learn moreOrtho® Workstation Immunohematology Analyzer
Learn moreOrtho Optix™ Reader
Learn moreLyra® Assays
Learn moreSavanna® Platform
Learn moreQuickVue® Rapid Lateral-Flow Tests
Learn moreVitros® Systems
Learn moreTriage® System
Learn moreOrtho Vision® Swift Automated Immunohematology System
Learn moreWe are driven to transform diagnostic data into answers, understanding and action for more people in more places every day. Learn how we help you chart the course forward in care.
News & Events
Press Release 08/29/24
VITROS® Syphilis Assay Now Available on VITROS 3600 Immunodiagnostic System, VITROS 5600 and VITROS XT 7600 Integrated Systems in the U.S.
Press Release 05/23/24
QuidelOrtho to Participate in 44th Annual William Blair Growth Stock Conference
Press Release 05/02/24
QuidelOrtho Appoints Brian J. Blaser as President and Chief Executive Officer
Press Release 04/10/24
QuidelOrtho Adds Fentanyl Test to Its Vitros® Systems as a MicroTip® Partnership Assay
Press Release 04/02/24